Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.92 USD | -8.06% | -2.39% | -51.89% |
07:06pm | UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating | MT |
Apr. 30 | Earnings Flash (TXG) 10X GENOMICS Reports Q1 Revenue $141M, vs. Street Est of $142.1M | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- TXG Stock
- Revisions 10x Genomics, Inc.